Literature DB >> 8769513

Pathophysiology of activity limitation in patients with interstitial lung disease.

J E Hansen1, K Wasserman.   

Abstract

OBJECTIVE: To analyze the relative importance of gas exchange, ventilatory, and circulatory abnormalities in limiting exercise in patients with interstitial lung disease. DESIGN AND
SETTING: Retrospective study at a referral cardiopulmonary exercise laboratory in a university/county medical center. PATIENTS AND METHODS: A database with more than 1,300 patients with incremental cycle exercise studies was screened to find 42 patients with interstitial lung disease, but without accompanying airflow limitation, chest wall, primary heart, or systemic vascular disease, or poor motivation. All had spirometry, lung volume, and gas transfer index measures at rest and repeated gas exchange, ventilatory, and circulatory measures during exercise; 37 of the 42 patients had multiple blood gas measures during exercise. We graded the gas exchange, ventilatory and circulatory dysfunction during maximally tolerated cycle ergometry and correlated the grades of dysfunction of these three components of respiration with percent predicted peak O2 uptake (peak Vo2).
RESULTS: Peak Vo2 values were not well correlated with the grades of ventilatory impairment but were well correlated with the grades of gas exchange and circulatory dysfunction. Patients who had reduced peak Vo2 values often had a normal breathing reserve with physiologic evidence of pulmonary vascular disease.
CONCLUSIONS: The pathophysiology of the pulmonary circulation is usually more important than ventilatory mechanics in limiting exercise in patients with interstitial lung disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769513     DOI: 10.1378/chest.109.6.1566

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  34 in total

1.  Cardiopulmonary exercise testing in differential diagnosis of dyspnea.

Authors:  Nora Toma; Gabriela Bicescu; Raluca Enache; Ruxandra Dragoi; Mircea Cinteza
Journal:  Maedica (Buchar)       Date:  2010-07

Review 2.  Respiratory and lower limb muscle function in interstitial lung disease.

Authors:  Marios Panagiotou; Vlasis Polychronopoulos; Charlie Strange
Journal:  Chron Respir Dis       Date:  2016-01-14       Impact factor: 2.444

Review 3.  Current best practice in rehabilitation in interstitial lung disease.

Authors:  Atsuhito Nakazawa; Narelle S Cox; Anne E Holland
Journal:  Ther Adv Respir Dis       Date:  2016-11-15       Impact factor: 4.031

4.  Weight gain after lung reduction surgery is related to improved lung function and ventilatory efficiency.

Authors:  Victor Kim; Dana M Kretschman; Alice L Sternberg; Malcolm M DeCamp; Gerard J Criner
Journal:  Am J Respir Crit Care Med       Date:  2012-08-09       Impact factor: 21.405

5.  Does nebulized fentanyl relieve dyspnea during exercise in healthy man?

Authors:  Houssam G Kotrach; Jean Bourbeau; Dennis Jensen
Journal:  J Appl Physiol (1985)       Date:  2015-03-12

6.  Impact of Psychological Deficits and Pain on Physical Activity of Patients with Interstitial Lung Disease.

Authors:  Seo Am Hur; Sabina A Guler; Nasreen Khalil; Pat G Camp; Jordan A Guenette; Christopher J Ryerson
Journal:  Lung       Date:  2019-06-01       Impact factor: 2.584

7.  Physiological mechanisms of dyspnea during exercise with external thoracic restriction: role of increased neural respiratory drive.

Authors:  Cassandra T Mendonca; Michele R Schaeffer; Patrick Riley; Dennis Jensen
Journal:  J Appl Physiol (1985)       Date:  2013-12-19

8.  Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.

Authors:  Jason M Elinoff; Richa Agarwal; Christopher F Barnett; Raymond L Benza; Michael J Cuttica; Ahmed M Gharib; Michael P Gray; Paul M Hassoun; Anna R Hemnes; Marc Humbert; Todd M Kolb; Tim Lahm; Jane A Leopold; Stephen C Mathai; Vallerie V McLaughlin; Ioana R Preston; Erika B Rosenzweig; Oksana A Shlobin; Virginia D Steen; Roham T Zamanian; Michael A Solomon
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

9.  The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis.

Authors:  Charlene D Fell; Lyrica Xiaohong Liu; Caroline Motika; Ella A Kazerooni; Barry H Gross; William D Travis; Thomas V Colby; Susan Murray; Galen B Toews; Fernando J Martinez; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2008-12-12       Impact factor: 21.405

10.  MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study.

Authors:  Effrosyni D Manali; Panagiotis Lyberopoulos; Christina Triantafillidou; Likourgos F Kolilekas; Christina Sotiropoulou; Joseph Milic-Emili; Charis Roussos; Spyros A Papiris
Journal:  BMC Pulm Med       Date:  2010-05-28       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.